trending Market Intelligence /marketintelligence/en/news-insights/trending/JSy8eqV3HtXtJ4cs_S8M1Q2 content esgSubNav
In This List

Argos Therapeutics board member resigns

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Argos Therapeutics board member resigns

Ralph Snyderman resigned from the board of Argos Therapeutics Inc., effective March 31.

There were no disagreements between Snyderman and the company or any officer or director of the company that led to the resignation.

Snyderman had served on the board since December 2016.